DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Clinical trial NCT06953089 · RECRUITING
Trial details
- NCT number
- NCT06953089
- Sponsor
- DualityBio Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2030-06-30
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.